GlassScriptPhysician profile
Timothy D Adkins
NPI 1932203338
$4,237.71
in general payments reported to CMS, 2019-2025
49 companies · $1,046 in 2025
The $1,046 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $801 · 2020: $304 · 2021: $61.46 · 2022: $548 · 2023: $628 · 2024: $849 · 2025: $1,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,523.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $777.66 | 2020-2025 | Ams 700, Moses 550 Dfl, Lithovue Empower |
| Antares Pharma, INC. | $327.17 | 2019-2025 | Xyosted |
| Astellas Pharma US INC | $269.85 | 2019-2024 | Xtandi |
| Pfizer INC. | $200.59 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $189.83 | 2019-2025 | Adstiladrin |
| Urogen Pharma, INC. | $169.55 | 2022-2025 | Jelmyto |
| Axonics, INC. | $167.34 | 2022-2024 | Axonics |
| Sumitomo Pharma America, INC. | $139.40 | 2023-2025 | Orgovyx, Gemtesa |
| Olympus America INC. | $126.64 | 2024-2025 | Itind System |
| Davol INC. | $125.64 | 2019 | |
| Janssen Biotech, INC. | $114.72 | 2019-2024 | Erleada |
| Abbvie INC. | $103.82 | 2022-2025 | |
| Procept Biorobotics Corporation | $100.32 | 2024 | Aquabeam System |
| Sanofi-Aventis U.S. LLC | $99.99 | 2020 | |
| Convatec INC. | $96.92 | 2023-2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Adkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.